Literature DB >> 22867840

Quantification of acetaminophen and two of its metabolites in human plasma by ultra-high performance liquid chromatography-low and high resolution tandem mass spectrometry.

David Tonoli1, Emmanuel Varesio, Gérard Hopfgartner.   

Abstract

The quantification of acetaminophen (APAP) and two of its metabolites, i.e. acetaminophen-glucuronide (APAP-GLUC) and acetaminophen-cysteine (APAP-CYS), is described in human plasma using ultra-high performance liquid chromatography coupled to a triple quadrupole linear ion trap mass spectrometer operating in the selected reaction monitoring (SRM/MS) mode and to a high resolution quadrupole time-of -flight mass spectrometer operating in the MS/MS (HR-SRM/MS) mode. Starting with a 50 μL plasma aliquot, a generic sample preparation was performed using protein precipitation with methanol/ethanol. Both methods were found to be linear over 2.5 orders of magnitude. Similar performances to the SRM/MS assay were obtained for APAP, APAP-CYS and APAP-GLUC using high resolution-selected reaction monitoring mode with LLOQ of 20, 50 and 50 ng/mL, respectively. For all analytes, precision was found to be better than 12% and accuracy in the range 90.3-109%. The present study demonstrates the ability of QqTOF platforms for accurate and precise quantification in MS/MS mode using short duty cycle with similar sensitivity to LC-SRM/MS. Additionally, as full scan data MS(ALL) are available qualitative and quantitative information on metabolites can also be obtained in a single LC-MS run.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22867840     DOI: 10.1016/j.jchromb.2012.07.009

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-31       Impact factor: 2.441

2.  Characterizing the Effects of Race/Ethnicity on Acetaminophen Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

3.  Comparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Rachel R Taylor; Keith L Hoffman; Björn Schniedewind; Claudia Clavijo; Jeffrey L Galinkin; Uwe Christians
Journal:  J Pharm Biomed Anal       Date:  2013-04-16       Impact factor: 3.935

4.  Ranking Fragment Ions Based on Outlier Detection for Improved Label-Free Quantification in Data-Independent Acquisition LC-MS/MS.

Authors:  Aivett Bilbao; Ying Zhang; Emmanuel Varesio; Jeremy Luban; Caterina Strambio-De-Castillia; Frédérique Lisacek; Gérard Hopfgartner
Journal:  J Proteome Res       Date:  2015-10-14       Impact factor: 4.466

5.  Quantitation of paracetamol by liquid chromatography-mass spectrometry in human plasma in support of clinical trial.

Authors:  Richard Kin-Ting Kam; Michael Ho-Ming Chan; Hiu-Ting Wong; Aniruddha Ghose; Arjen M Dondorp; Katherine Plewes; Joel Tarning
Journal:  Future Sci OA       Date:  2018-08-15

6.  RP-LC and TLC Densitometric Determination of Paracetamol and Pamabrom in Presence of Hazardous Impurity of Paracetamol and Application to Pharmaceuticals.

Authors:  Ola Mohamed El-Houssini
Journal:  Anal Chem Insights       Date:  2013-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.